VR Insurance Holdings, Inc. Announces Acquisition of The National Security Group, Inc.
“We believe this transaction is in the best interest of NSG’s shareholders and policyholders,” said
The Company’s Board of Directors has unanimously approved the transaction and recommended that NSG’s shareholders vote in favor of the transaction. The agreement requires approval by holders of the majority of NSG’s outstanding common shares. The acquisition is expected to close by the end of the second quarter of 2022, subject to customary closing conditions, including receipt of certain required regulatory approvals and approval of NSG’s shareholders. There are no financing conditions associated with the definitive merger agreement.
Following closing, it is anticipated that
[1] The price per share is subject to downward adjustment if the combined statutory capital and surplus of NSG’s insurance subsidiaries is less than
About
About
About
Additional Information and Where to Find It
In connection with the proposed transaction,
Participants in the Solicitation
Cautionary Statement Regarding Forward-Looking Statements
Any statement contained in this report which is not a historical fact, or which might otherwise be considered an opinion or projection concerning the Company or its business, whether expressed or implied, is meant as and should be considered a forward-looking statement as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions and opinions concerning a variety of known and unknown risks, including but not limited to changes in market conditions, natural disasters and other catastrophic events, increased competition, changes in availability and cost of reinsurance, changes in governmental regulations, technological changes, political and legal contingencies and general economic conditions, as well as other risks and uncertainties more completely described in the Company’s filings with the
The proposed transaction is subject to risks and uncertainties, including: (A) that
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20220126006009r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20220126006009/en/
(334) 897-2273
Source:
Patent Issued for Systems and methods of processing and reconciling healthcare related claims (USPTO 11217346): Accumulation Technologies LLC
Seoul National University Hospital Reports Findings in Brain Cancer (Association of Zolpidem With Increased Mortality in Patients With Brain Cancer: A Retrospective Cohort Study Based on the National Health Insurance Service Database): Oncology – Brain Cancer
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News